1-5 of 5
Ana Alfonso Pierola, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of the Next-Generation Sequencing Panel on Treatment Choice in Patients with Myelodysplastic Syndrome

Ana Alfonso Pierola, MDPhD, Guillermo Montalban-Bravo, MD, Ali N. Chamseddine, MD, Koichi Takahashi, MD, Feng Wang, PhD, Song Xingzhi, Elias J. Jabbour, MD, Tapan M. Kadia, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Courtney D. DiNardo, MD MSCE, Naval G. Daver, MD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Marina Konopleva, MD PhD, Carlos E Bueso-Ramos, MD PhD, Keyur Patel, MD, Andrew Futreal, PhD, Sherry Pierce, BSN, BA, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2016) 128 (22): 4340.
https://doi.org/10.1182/blood.V128.22.4340.4340
Published: 2016
Journal Articles

The Role of Chip-Related DNA Damage Response Dysfunction in Therapy-Related Myeloid Neoplasms

Ana Alfonso Pierola, MDPhD, Matteo Marchesini, PhD, Koichi Takahashi, MD, Irene Gañán-Gómez, PhD, Elena Fiorini, MS, Yamini Ogoti, MS, Esperanza Irles, PhD, Guillermo Montalban-Bravo, MD, Silver Sofia, BS, Karen C. Dwyer, PhD, Guillermo Garcia-Manero, MD, Simona Colla, PhD
Journal: Blood
Blood (2016) 128 (22): 958.
https://doi.org/10.1182/blood.V128.22.958.958
Published: 2016
Journal Articles

Myelodysplastic Syndromes with NPM1 Mutations May Constitute a Unique Entity Associated with Improved Outcomes When Treated with AML-like Chemotherapy

Guillermo Montalban-Bravo, MD, Ana Alfonso Pierola, MDPhD, Koichi Takahashi, MD, Elias J. Jabbour, MD, Tapan M. Kadia, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Courtney D. DiNardo, MD MSCE, Naval G. Daver, MD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Marina Konopleva, MD PhD, Sherry Pierce, BSN, BA, Carlos E Bueso-Ramos, MD PhD, Keyur Patel, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2016) 128 (22): 3171.
https://doi.org/10.1182/blood.V128.22.3171.3171
Published: 2016
Journal Articles

Initial Results of a Phase 2 Study of Guadecitabine (SGI-110), a Novel Subcutaneous (sc) Hypomethylating Agent, for Patients with Previously Untreated Intermediate-2 or High Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Guillermo Montalban-Bravo, MD, Prithviraj Bose, MD, Yesid Alvarado, MD, Naval Daver, MD, Farhad Ravandi, MD, Gautam Borthakur, MD, Koichi Takahashi, MD, Michael Andreeff, MD PhD, Jorge E. Cortes, MD, Courtney D. DiNardo, MD MSCE, Elias Jabbour, MD, Tapan M. Kadia, MD, Steven M. Kornblau, MD, Maro Ohanian, DO, Ana Alfonso Pierola, MDPhD, Xuelin Huang, PhD, Graciela M. Nogueras-Gonzalez, Kristy Bodden, Kristina Littles, Sherry Pierce, BSN, BA, Carlos E Bueso-Ramos, MD PhD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2016) 128 (22): 346.
https://doi.org/10.1182/blood.V128.22.346.346
Published: 2016
Journal Articles

Activity of Hypomethylating Agents in the Treatment of Therapy-Related Myelodysplastic Syndrome

Ana Alfonso Pierola, MDPhD, Guillermo Montalban-Bravo, MD, Koichi Takahashi, MD, Feng Wang, PhD, Song Xingzhi, Elias J. Jabbour, MD, Tapan M. Kadia, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Courtney D. DiNardo, MD MSCE, Naval G. Daver, MD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Marina Konopleva, MD PhD, Carlos E Bueso-Ramos, MD PhD, Keyur Patel, MD, Andrew Futreal, PhD, Sherry Pierce, BSN, BA, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2016) 128 (22): 3177.
https://doi.org/10.1182/blood.V128.22.3177.3177
Published: 2016